Dmitry Kulish

Biography

Professor Kulish expertise spans through strategic, organizational, and technology topics in Russian and global pharmaceutical and biotechnology industries, as well as innovation in general. During his 20+-year career, Dmitry has managed and led Russian and international teams with emphasis on pharmaceutical innovation, venture development, product development and manufacturing.  He served at the top executive positions at prominent Russian pharmas (R-Pharm, Nanolek, Bioprocess-Pharmapark), esteemed MNCs (Fresenius Kabi and Intel Capital), as well as budding biotech start-ups. After completing the corporate career in 2014, Professor Kulish established a consultancy “DrugDevelopment.Ru” that advises pharmaceutical and investment companies on the broad range of strategic and operational issues related to Russian and global pharmaceutical business. At Skoltech CEI Professor Kulish leads the pharmaceutical practice based on three interdependent activities: Teaching pharmaceutical entrepreneurship and industrial knowledge through the course “Industrial Applications of Biomedical Sceince” as well as through the Professor Dubinsky acclaimed course “Innovation Workshop”. Both courses are unique for Russia and aim to grow beyond Skoltech by inviting students of different schools to visit and join activities at the hub of entrepreneurship and innovation Mentoring Skoltech student pharmaceutical-related projects with the goal of producing commercially successful start-ups of global value Publishing proprietary non-profit research in the area of infrastructure and economics of Russian and global pharmaceutical innovation and product development Professor Kulish holds PhD in Biochemistry from Moscow Institute of Molecular Genetics,   MBA in Business Strategy from the Wharton School of Business, and MA in Biotechnology from Moscow Institute of Fine Chemical Technology. Dmitry was a Postdoctoral Fellow in Molecular Pharmacology at Harvard University.

Research Interest

Pharmaceutical innovation, venture development, product development and manufacturing